Welcome to our dedicated page for UiPath SEC filings (Ticker: PATH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
UiPath SEC filings document material events for an enterprise automation software company listed under PATH. Recent Form 8-K disclosures cover operating and financial results, executive leadership and compensation arrangements, annual meeting voting outcomes, and governance matters including director elections, advisory compensation votes, and auditor ratification.
The filings also record capital-structure subjects tied to UiPath's Class A and Class B common stock, including stockholder trading-plan disclosures. These records frame PATH's public-company reporting around results releases, board and officer matters, stockholder votes, and equity ownership structure.
UiPath (PATH) Form 4: The company’s Chief Accounting Officer reported a sale of Class A common stock. On 10/20/2025, the officer sold 10,000 shares at $15.65 per share, disclosed with transaction code “S”. The filing notes the sale was made under a qualified Rule 10b5-1 trading plan.
Following this transaction, the reporting person beneficially owns 202,776 shares with direct ownership.
UiPath (PATH) reported an insider transaction by its Chief Accounting Officer. On 10/17/2025, the officer sold 10,000 shares of Class A common stock at an average price of $15.7345, executed under a qualified Rule 10b5-1 trading plan. Following the sale, the officer beneficially owns 212,776 shares directly. The filing notes a transaction price range from $15.6000 to $15.8700.
UiPath (PATH) insider transaction: CEO and Chairman Daniel Dines, also a Director and 10% Owner, reported a sale of 45,000 shares of Class A common stock at $15.62 on 10/17/2025. The filing notes the sale was executed under a qualified Rule 10b5-1 trading plan.
Following the transaction, he beneficially owned 29,873,585 shares directly. An additional 240,000 shares are reported as indirectly owned by his spouse.
Form 144 filing: A holder filed notice to sell up to 35,000 shares of common stock. The filing lists an aggregate market value of $557,550, an approximate sale date of 10/17/2025, execution through Morgan Stanley Smith Barney LLC, and NYSE as the exchange.
The shares to be sold were acquired as Restricted Stock Units on 01/01/2024 in the amount of 35,000. Shares outstanding were 453,568,899 as of the filing’s disclosure.
The filer reported recent Rule 10b5-1 sales of 10,000 shares on 10/13/2025 ($170,056), 10/14/2025 ($165,351), 10/15/2025 ($166,801), and 10/16/2025 ($163,521).
PATH common stock: a Form 144 notice discloses a proposed sale of 1,000,000 shares, with an aggregate market value $15,930,000. The filing lists Morgan Stanley Smith Barney LLC – Executive Financial Services as broker and an approximate sale date of 10/17/2025 on the NYSE.
The securities were acquired on 04/21/2021 as Founders Shares from the issuer; amount acquired was 1,000,000 shares. Shares outstanding were 453,568,899. The filing also reports recent Rule 10b5-1 sales by ICE VULCAN HOLDING LIMITED, including 122,734 shares on 10/16/2025 for $2,112,411.69.
UiPath, Inc. (PATH) insider transaction: CEO, Chairman, Director, and 10% owner Daniel Dines reported a sale of 122,734 Class A shares on 10/16/2025. The sale was executed under a qualified Rule 10b5-1 trading plan. The filing notes a weighted average price of $17.2113, with individual trade prices ranging from $16.7400 to $17.4700.
Following the reported transactions, the filing lists 29,918,585 Class A shares as directly beneficially owned and 240,000 shares indirectly beneficially owned by spouse. The form also references indirect holdings through Ice Vulcan Holding Limited, over which Mr. Dines has sole voting and investment power via control of the parent entity.
UiPath (PATH) reported an insider transaction by its Chief Accounting Officer. On 10/16/2025, the officer sold a total of 10,000 Class A shares in two trades executed under a pre‑arranged Rule 10b5-1 plan.
The first sale was 8,300 shares at a weighted average price of $16.2211 (price range $15.8100–$16.7700). The second was 1,700 shares at a weighted average price of $16.9918 (range $16.8100–$17.4900). Following these transactions, the officer beneficially owns 222,776 shares, held directly.
UiPath (PATH) filed a Form 144 notice for a proposed sale of 10,000 common shares with an aggregate market value of $166,900. The filing lists Morgan Stanley Smith Barney LLC as broker, an approximate sale date of 10/16/2025, and trading on the NYSE. The shares were acquired via restricted stock units from the issuer on 01/01/2024. Shares outstanding were 453,568,899.
The filing also reports recent Rule 10b5-1 sales for Hitesh Ramani: 10,000 shares on 10/13/2025 for $170,056, 10,000 on 10/14/2025 for $165,351, and 10,000 on 10/15/2025 for $166,801.
UiPath (PATH) reported an insider transaction by its GC & Chief Legal Officer, Brad Brubaker. On 10/15/2025, he sold 27,580 shares of Class A common stock in an open-market transaction executed under a Rule 10b5-1 trading plan.
The reported average price was $16.6761, with trades occurring in a range from $16.2100 to $17.2000. Following the sale, Brubaker beneficially owns 662,939 shares, held directly.
UiPath (PATH) CEO Daniel Dines reported an insider sale. A Form 4 shows the sale of 122,734 shares of Class A common stock on 10/15/2025, executed pursuant to a Rule 10b5-1 trading plan.
The filing lists a price of $16.9245 and notes trades occurred within a range of $16.7200 to $17.0600. Footnotes indicate certain shares are held through Ice Vulcan Holding Limited, with Mr. Dines retaining sole voting and investment power through affiliated entities. He is identified as Director, CEO and Chairman, and a 10% Owner.